Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Gastroenterology Clinics of North America
|
May 17, 2017
Hepatic Progenitor Cells: An Update
Matthias Van Haele, Tania Roskams
International Journal of Molecular Sciences
|
May 15, 2019
Human Liver Regeneration: An Etiology Dependent Process
Matthias Van Haele, Janne Snoeck, Tania Roskams
Biochemical Pharmacology
|
July 18, 2018
HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis
Mohammed Benkheil, Jan Paeshuyse, Johan Neyts, et al.
Journal of Clinical Pathology
|
July 13, 2019
Rapid clinical mutational testing of <i>KRAS</i>, <i>BRAF</i> and <i>EGFR</i>: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
Matthias Van Haele, Sara Vander Borght, An Ceulemans, et al.
Cell Death & Disease
|
November 3, 2017
RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
An Ceulemans, Stefaan Verhulst, Matthias Van Haele, et al.
Experimental Cell Research
|
October 6, 2018
CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer
Mohammed Benkheil, Matthias Van Haele, Tania Roskams, et al.
Frontiers in Oncology
|
August 22, 2022
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level
Francesca Maria Bosisio, Yannick Van Herck, Julie Messiaen, et al.
International Journal of Molecular Sciences
|
February 6, 2019
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Matthias Van Haele, Iván M Moya, Ruçhan Karaman, et al.
Clinical Epigenetics
|
February 16, 2020
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
Eva Galle, Bernard Thienpont, Sarah Cappuyns, et al.
Theranostics
|
January 7, 2020
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells activation
Oriana Lo Re, Tommaso Mazza, Sebastiano Giallongo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Gastroenterology Clinics of North America
|
May 17, 2017
Hepatic Progenitor Cells: An Update
Matthias Van Haele, Tania Roskams
International Journal of Molecular Sciences
|
May 15, 2019
Human Liver Regeneration: An Etiology Dependent Process
Matthias Van Haele, Janne Snoeck, Tania Roskams
Biochemical Pharmacology
|
July 18, 2018
HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis
Mohammed Benkheil, Jan Paeshuyse, Johan Neyts, et al.
Journal of Clinical Pathology
|
July 13, 2019
Rapid clinical mutational testing of <i>KRAS</i>, <i>BRAF</i> and <i>EGFR</i>: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing
Matthias Van Haele, Sara Vander Borght, An Ceulemans, et al.
Cell Death & Disease
|
November 3, 2017
RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
An Ceulemans, Stefaan Verhulst, Matthias Van Haele, et al.
Experimental Cell Research
|
October 6, 2018
CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer
Mohammed Benkheil, Matthias Van Haele, Tania Roskams, et al.
Frontiers in Oncology
|
August 22, 2022
Next-Generation Pathology Using Multiplexed Immunohistochemistry: Mapping Tissue Architecture at Single-Cell Level
Francesca Maria Bosisio, Yannick Van Herck, Julie Messiaen, et al.
International Journal of Molecular Sciences
|
February 6, 2019
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Matthias Van Haele, Iván M Moya, Ruçhan Karaman, et al.
Clinical Epigenetics
|
February 16, 2020
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
Eva Galle, Bernard Thienpont, Sarah Cappuyns, et al.
Theranostics
|
January 7, 2020
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells activation
Oriana Lo Re, Tommaso Mazza, Sebastiano Giallongo, et al.
Page
of 3